Americann
ACAN · OTC
About ACAN
- Employees
- 3
- Headquarters
- Denver, Colorado
- Listed
- Sep 10, 2013
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Website
- americann.co
ACAN key statistics
- Market cap
- 2.44K
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 12.74K
- Volume
- 10
- Open price
- $0.0001
- High today
- $0.0001
- Low today
- $0.0001
- 52 Week high
- $0.0113
- 52 Week low
- $0.00
Americann (ACAN) at a glance
Americann (ACAN) last traded at $0.0001, with a market cap of 2.44K and a price-to-earnings ratio of 0.00.
Volume so far is 10 shares, below the average of 12.74K shares a day.
Over the past year Americann has ranged from $0.00 to $0.0113, and now sits 1% of the way up that range.
Similar companies
Companies in the same industry as Americann
Most active stocks
Highest trading volume today
- SHFSSHF Holdings$0.0899−4.36%
- WHLRWheeler Real Estate Investment Trust$0.3597+2.19%
- RBNERobin Energy$0.3978−23.65%
- OLOXOlenox Industries$0.737+5.18%
- SDSTStardust Power$0.02−23.66%
- RCTRedCloud Holdings$0.084+1.94%
- WFFWF Holding$0.0929−3.83%
- AHTAshford Hospitality Trust$1.79−2.72%
- SPCXSpace Exploration Technologies$147.79−0.11%
- NIVFNewGenIvf Group$0.2499−11.73%
- NWGLCL Workshop Group$0.1522+27.90%
- DKIDarkiris$0.0479−6.08%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.